Difference between revisions of "Resource:B2456a64-b3e1-4d36-866e-a3ba117633e9"

From The Embassy of Good Science
Line 11: Line 11:
 
}}
 
}}
 
{{Related To
 
{{Related To
 +
|Related To Resource=Resource:366d47ee-4b9d-4287-8c57-88ba847480bb;Resource:F68f2226-005e-4321-b2a4-fc541fdf6c8d;Resource:740210e9-b695-428b-90a3-f3af7a94a174;Resource:E8743444-88e1-46a7-a1c0-25ca501c0886
 
|Related To Theme=Theme:5f65272f-6e95-4768-8236-bc821a97f3d8;Theme:047c3bec-1747-499b-b6d5-684cbfb81edd
 
|Related To Theme=Theme:5f65272f-6e95-4768-8236-bc821a97f3d8;Theme:047c3bec-1747-499b-b6d5-684cbfb81edd
 
}}
 
}}

Revision as of 13:46, 28 September 2020

Cases

Handling of Scientific Dishonesty in the Nordic Countries: Early stages in the 1990's

What is this about?

Scientific dishonesty in medical research has received increased attention over recent years. A survey among 274 medical scientists in Norway showed that 22% knew about cases of serious misconduct, and 3% were aware of falsification or fabrication of data. 9% of the respondents had themselves contributed to one or more incidents of misconduct[1]. This is a factual anonymized case.
  1. Nylenna, Magne, et al. "Handling of scientific dishonesty in the Nordic countries." The Lancet 354.9172 (1999): 57-61.

Why is this important?

Committees were established by the national medical research councils in Denmark (1992), Norway (1994), and Sweden (1997), and by the Ministry of Education in Finland (1994), to deal with scientific misconduct - i.e, to initiate preventive measures, to investigate alleged cases, or both[1]. This article describes Nordic systems of handling misconduct allegations and investigations in the 1990s.

  1. Nylenna, Magne, et al. "Handling of scientific dishonesty in the Nordic countries." The Lancet 354.9172 (1999): 57-61.

For whom is this important?

Other information

When
Virtues & Values
Good Practices & Misconduct
Research Area
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
5.1.6